The technology is so sophisticated it can account for the effects of medication on the disease. This means it can also be used to monitor the effectiveness of treatment and the severity of a patient’s condition. It’s also able to provide more detail about a patient’s symptoms to their treating doctors.
Despite its sophistication, the screening test is relatively simple. It requires patients to complete seven dexterity tasks on a drawing tablet, from writing to joining dots in a spiral shape. Upon completion, the test creates a patient-specific baseline for different aspects of complicated Parkinson’s symptoms.
Data from the screening test are transmitted over the cloud and customised software records the results, analysing them in real time. This software is readily compatible with existing technologies so the screening test can be easily completed using only a pen, paper and drawing tablet.
“The standard multi-modal physical tests carried out by clinicians to monitor its progress inherently carry a level of subjectivity. Our technology is completely objective and it’s highly sensitive for both improvements and deterioration in dexterity. As our population ages, the number of people living with Parkinson’s is expected to increase dramatically, so knowing more precisely how the disease is progressing and understanding the effect of different treatments will be crucial in helping them manage their condition,” said Professor Kumar.